Hepion Pharmaceuticals, Inc.
HEPA
$0.06
$0.00-1.54%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 59.62% | 52.19% | 57.31% | 73.04% | 49.18% |
| Total Depreciation and Amortization | -100.00% | -100.00% | -100.00% | -54.10% | -41.20% |
| Total Amortization of Deferred Charges | 67.34% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 409.24% | 300.56% | -103.70% | -172.83% | -31.81% |
| Change in Net Operating Assets | 105.31% | 127.85% | 82.84% | -190.30% | -169.11% |
| Cash from Operations | 84.30% | 82.28% | 56.69% | 55.45% | 28.95% |
| Capital Expenditure | -- | -- | -- | -- | 99.01% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 77.98% | -- | -- | -- | -- |
| Cash from Investing | 77.99% | -31,930.43% | -4,125.35% | -4,125.35% | -1,887.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.76% | 81.25% | 81.25% | -3.23% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -43.63% | 20.46% | 22.90% | -3.23% | 381.90% |
| Foreign Exchange rate Adjustments | 83.48% | 108.03% | -99.45% | 1,607.84% | 489.66% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 104.63% | 102.85% | 71.50% | 60.50% | 55.38% |